Quotient Sciences
Building a best-in-class pharmaceutical services business, Quotient Sciences takes an innovative approach to drug development.
Through its unique Translational Pharmaceutics platform, Quotient can accelerate the drug development process, enabling its pharmaceutical and biotech customers to reduce the time and cost of bringing a new drug to market.
Through its unique Translational Pharmaceutics platform, Quotient can accelerate the drug development process, enabling its pharmaceutical and biotech customers to reduce the time and cost of bringing a new drug to market.
2019
Investment year
£140m+
Annual revenues
275+
Molecules